Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

605
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
605
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

476
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
476
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

316
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
316
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

459
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
459
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

942
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
942
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

493
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
493

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease.

Atherosclerosis·2017
Same author

Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.

American heart journal·2017
Same author

Gamma prime (γ') fibrinogen and carotid intima-media thickness: the Atherosclerosis Risk in Communities study.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2017
Same author

Cardiovascular Event Prediction by Machine Learning: The Multi-Ethnic Study of Atherosclerosis.

Circulation research·2017
Same author

Failure to replicate thrombomodulin genetic variant predictors of venous thromboembolism in African Americans.

Blood·2017
Same author

Association of Educational Attainment With Lifetime Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.

JAMA internal medicine·2017

Related Experiment Video

Updated: Feb 23, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

675

Accuracy of Self-Reported Heart Failure. The Atherosclerosis Risk in Communities (ARIC) Study.

Ricky Camplain1, Anna Kucharska-Newton2, Laura Loehr2

  • 1Center for Health Equity, Northern Arizona University, Flagstaff, Arizona; Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina, United States of America.

Journal of Cardiac Failure
|September 13, 2017
PubMed
Summary

Patient self-reports of heart failure (HF) show low sensitivity and poor agreement with physician diagnoses. Confirmation via diagnostic tests or medical records is crucial for accurate HF burden estimation.

Keywords:
Heart failureadministrative claimsmedical recordsself-report

More Related Videos

Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
06:57

Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection

Published on: September 22, 2023

1.5K

Related Experiment Videos

Last Updated: Feb 23, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

675
Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
06:57

Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection

Published on: September 22, 2023

1.5K

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Heart failure (HF) is a significant public health concern.
  • Accurate estimation of HF prevalence is essential for resource allocation and patient management.
  • Discrepancies between patient self-reporting and clinical diagnosis can impact prevalence estimates.

Purpose of the Study:

  • To assess the agreement between self-reported heart failure (HF) and physician-diagnosed HF.
  • To compare the prevalence of HF based on different ascertainment methods.

Main Methods:

  • Analysis of the ARIC cohort (ages 60-83) with annual self-report surveys on HF.
  • Physician confirmation of self-reported HF cases.
  • Inclusion of hospitalized HF surveillance and administrative claims data (hospitalized and outpatient) for physician-diagnosed HF.
  • Calculation of sensitivity, specificity, kappa, and prevalence, including bias-adjusted kappa (PABAK).

Main Results:

  • Self-reported HF demonstrated low sensitivity (28%-38%) but high specificity (96%-97%) compared to physician diagnoses.
  • Initial agreement was poor (kappa: 0.32-0.39), improving significantly when adjusted for prevalence and bias (PABAK: 0.73-0.83).
  • Prevalence estimates were similar for self-report (9.0%), ARIC hospitalizations (11.2%), and hospitalization claims (12.7%), but increased to 18.6% when outpatient claims were included.

Conclusions:

  • Self-reported HF requires confirmation through diagnostic tests or medical records for accurate burden estimation.
  • Improved patient awareness and understanding of HF diagnosis are necessary for effective condition management.
  • Ascertainment methods significantly influence HF prevalence estimates, highlighting the need for robust diagnostic validation.